BackBluejay Diagnostics Overview

Bluejay Diagnostics Receivables

Track Bluejay Diagnostics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Bluejay Diagnostics Receivables History

Loading

Bluejay Diagnostics vs. peers: Receivables Comparison

Loading

Bluejay Diagnostics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bluejay Diagnostics (BJDX) FAQ

As of the most recent data (June 2026), BJDX shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BJDX's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bluejay Diagnostics is outperforming or lagging.

Tracking BJDX's receivables over time shows whether Bluejay Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Bluejay Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.